Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs

被引:23
|
作者
Zhang, Lingzi [1 ]
Zhan, Peng [1 ]
Chen, Xuwang [1 ]
Li, Zhenyu [1 ]
Xie, Zhoumeng [1 ]
Zhao, Tong [1 ]
Liu, Huiqing [3 ]
De Clercq, Erik [2 ]
Pannecouque, Christophe [2 ]
Balzarini, Jan [2 ]
Liu, Xinyong [1 ]
机构
[1] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Key Lab Chem Biol,Minist Educ, Jinan 250012, Shandong, Peoples R China
[2] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[3] Shandong Univ, Inst Pharmacol, Sch Med, Jinan 250012, Shandong, Peoples R China
基金
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词
HIV-1; AIDS; NNRTIs; Synthesis; Anti-HIV-1; activity; REVERSE-TRANSCRIPTASE INHIBITORS; COLORIMETRIC ASSAY; ANTAGONISTS; DISCOVERY; AIDS; DNA;
D O I
10.1016/j.bmc.2013.10.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of novel N-arylmethyl substituted piperidine-linked aniline derivatives were designed, synthesized and evaluated for their anti-HIV activity in MT-4 cells. All the new compounds showed moderate to potent activities against wild-type (wt) HIV-1 with an EC50 range from 0.022 to 2.1 mu M. Among them, compound 5a6 (EC50 = 0.022 +/- 0.0091 mu M, SI > 10,770) was confirmed to be the most potent and selective inhibitor, which proved more potent than DDI and DLV in a cell-based assay against wt HIV-1, and more efficient than NVP in an RT (reverse transcriptase) assay. Besides, it is worth noting that compound 7a1 retained moderate inhibitory activity (EC50 = 4.8 +/- 0.95 mu M) against the HIV-1 double RT mutant strain (K103N/Y181C). The preliminary structure-activity relationship was discussed and rationalized by molecular simulation. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:633 / 642
页数:10
相关论文
共 39 条
  • [1] Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies
    Zhan, Peng
    Liu, Xinyong
    Li, Zhenyu
    Fang, Zengjun
    Li, Zhong
    Wang, Defeng
    Pannecouque, Christophe
    De Clercq, Erik
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (16) : 5920 - 5927
  • [2] Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs
    Liu, Zhaoqiang
    Tian, Ye
    Liu, Jinghan
    Huang, Boshi
    Kang, Dongwei
    De Clercq, Erik
    Daelemans, Dirk
    Pannecouque, Christophe
    Zhan, Peng
    Liu, Xinyong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 140 : 383 - 391
  • [3] Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs
    Rai, Diwakar
    Chen, Wenmin
    Tian, Ye
    Chen, Xuwang
    Zhan, Peng
    De Clercq, Erik
    Pannecouque, Christophe
    Balzarini, Jan
    Liu, Xinyong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (23) : 7398 - 7405
  • [4] Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs
    Gao, Ping
    Song, Shu
    Wang, Zhao
    Sun, Lin
    Zhang, Jian
    Pannecouque, Christophe
    De Clercq, Erik
    Zhan, Peng
    Liu, Xinyong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 40
  • [5] 5-Cyano substituted diarylpyridines as potent HIV-1 NNRTIs: Rational design, synthesis, and activity evaluation
    Song, Hao
    Xia, Yu
    Zhang, Tao
    Dun, Caiyun
    Meng, Bairu
    De Clercq, Erik
    Pannecouque, Christophe
    Kang, Dongwei
    Zhan, Peng
    Liu, Xinyong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259
  • [6] Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs
    Wang, Zhao
    Yu, Zhao
    Kang, Dongwei
    Zhang, Jian
    Tian, Ye
    Daelemans, Dirk
    De Clercq, Erik
    Pannecouque, Christophe
    Zhan, Peng
    Liu, Xinyong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (03) : 447 - 456
  • [7] Design and synthesis of Fsp3-enriched spirocyclic-substituted diarylpyrimidine derivatives as novel HIV-1 NNRTIs
    Sang, Zihao
    Zhang, Tao
    Wang, Zhao
    De Clercq, Erik
    Pannecouque, Christophe
    Kang, Dongwei
    Zhan, Peng
    Liu, Xinyong
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (03)
  • [8] Design, synthesis, and antiviral evaluation of novel piperidine-substituted arylpyrimidines as HIV-1 NNRTIs by exploring the hydrophobic channel of NNIBP
    Zhang, Tao
    Zhou, Zhongxia
    Zalloum, Waleed A.
    Wang, Zhao
    Fu, Zhipeng
    Cherukupalli, Srinivasulu
    Feng, Da
    Sun, Yanying
    Gao, Shenghua
    De Clercq, Erik
    Pannecouque, Christophe
    Kang, Dongwei
    Zhan, Peng
    Liu, Xinyong
    BIOORGANIC CHEMISTRY, 2021, 116
  • [9] Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs
    Kang, Dongwei
    Feng, Da
    Ginex, Tiziana
    Zou, Jinmi
    Wei, Fenju
    Zhao, Tong
    Huang, Boshi
    Sun, Yanying
    Desta, Samuel
    De Clercq, Erik
    Pannecouque, Christophe
    Zhan, Peng
    Liu, Xinyong
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (05) : 878 - 894
  • [10] Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors
    Chen, Xuwang
    Zhan, Peng
    Liu, Xin
    Cheng, Ziheng
    Meng, Caicai
    Shao, Siyuan
    Pannecouque, Christophe
    De Clercq, Erik
    Liu, Xinyong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (12) : 3856 - 3864